NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
23 hedge funds and large institutions have $139K invested in Navidea Biopharmaceuticals Inc. in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$35.8K | |
| 2 | +$11.9K | |
| 3 | +$11.6K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$3.68K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$3.68K |
Top Sellers
| 1 | -$62K | |
| 2 | -$33K | |
| 3 | -$26.6K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$17.1K |
| 5 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$7.29K |